Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00496106 · ClinicalTrials.gov registry record · NA

Stress, Immunity and Cervical Cancer: Biobehavioral Outcomes

A NA study of Ovarian Cancer, sponsored by University of California, Irvine.

Completed
Registry status
NA
Development phase
204
Enrollment target
1
Study location

NCT00496106 is a NA study of Ovarian Cancer that has completed, run by University of California, Irvine. The registered enrollment target is 204 participants, below the 728-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00496106, a NA study of Ovarian Cancer, has completed, sponsored by University of California, Irvine.

COMPLETED
Registry status
NA
Development phase
204 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to: 1. Test the efficacy of psychosocial telephone counseling (PTC) for cervical cancer survivors, compared to usual care. 2. Evaluate the longitudinal immune and neuroendocrine parameters in cervical cancer patients who have received PTC, compared to usual care. 3. Examine the longitudinal relationship between PTC associated modulations of quality of life (QOL) measures and biologic parameters (immune and neuroendocrine).

Conditions Studied

Interventions

  • BEHAVIORAL Telephone counseling
  • BEHAVIORAL Telephone interview

Study Locations (1)

California

  • University of California, Irvine Medical Center - Orange

Trial Details

FieldValue
Enrollment Target 204 participants
Start Date 2007-08
Est. Completion 2011-02
Phase NA

Sponsor

University of California, Irvine

368 total trials

What the Registry Record Tells You About NCT00496106

The ClinicalTrials.gov registry entry for NCT00496106 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 204 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 728-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (72% lower). The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Ovarian Cancer appearing as the primary indexed condition, and to 2 interventions - of which Telephone counseling is the first listed.

NCT00496106 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00496106 about?

NCT00496106 is a clinical study titled "Stress, Immunity and Cervical Cancer: Biobehavioral Outcomes". The purpose of the study is to: 1. Test the efficacy of psychosocial telephone counseling (PTC) for cervical cancer survivors, compared to usual care. 2. Evaluate the longitudinal immune and neuroendocrine parameters in cervical cancer patients who have received PTC, compared to usual care. 3. Exam...

What is the current status of trial NCT00496106?

This trial is currently completed. It is a NA study. The enrollment target is 204 participants. The study started on 2007-08. Estimated completion is 2011-02.

What conditions does trial NCT00496106 study?

This clinical trial studies the following conditions: Ovarian Cancer.

What interventions are being tested in trial NCT00496106?

The interventions under investigation include: Telephone counseling (BEHAVIORAL), Telephone interview (BEHAVIORAL).

Who is sponsoring clinical trial NCT00496106?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00496106 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ovarian Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.